Fig. 1

Phase 3 study (SONIA 2) recruitment of 139 patients in a rare disease within 9 months demonstrating a constant recruitment rate throughout the period
Phase 3 study (SONIA 2) recruitment of 139 patients in a rare disease within 9 months demonstrating a constant recruitment rate throughout the period